Both in Surgical Instruments
SpyGlass Pharma vs iRadimed
Over the past year SGP returned +22.1% and IRMD returned −20.1%; their daily moves had a correlation of 0.10.
SGP +22.1% IRMD −20.1%Growth of $1, one year, split-adjusted
| Metric | SGP | IRMD |
|---|---|---|
| Price | $32.24 | $76.68 |
| Market cap | $1.08B | $980.5M |
| Today | −0.83% | −10.57% |
| 1 month | +21.7% | −10.1% |
| 6 months | +34.4% | −12.0% |
| Year to date | — | −21.2% |
| 1 year | — | −2.1% |
| Revenue growth (YoY) | — | +14.2% |
| Gross margin | — | 76.3% |
| Net margin | — | 26.9% |
| P/E (TTM) | — | 40.9× |
| Price / sales | — | 11.0× |
| Net cash | $234.2M | $63.3M |
| Dividend yield | — | 1.04% |
| Volatility (60d) | 45.9% | 30.3% |
| Short % of float | 20.6% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).